Kent Armeson to Protein Kinase Inhibitors
This is a "connection" page, showing publications Kent Armeson has written about Protein Kinase Inhibitors.
Connection Strength
0.298
-
Neuropilin-2b facilitates resistance to tyrosine kinase inhibitors in non-small cell lung cancer. J Thorac Cardiovasc Surg. 2021 08; 162(2):463-473.
Score: 0.152
-
Polo-like kinase 1 (Plk1) inhibition synergizes with taxanes in triple negative breast cancer. PLoS One. 2019; 14(11):e0224420.
Score: 0.146